ArticleCommunications biology2026
BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rare genetic diseases associated with G-quadruplex-induced replication stress.Communications biology · 2026Review
- G-Quadruplex Unwinding Molecular Mechanisms by Helicases and Their Applications.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
DNA G-quadruplexes (G4s) spontaneously arise in guanine-rich regions such as telomeres. Although G4s regulate essential biological process, their persistence can interfere with DNA metabolism and induce replication stress (RS). Helicases such as BLM and FANCJ play key roles in resolving G4 structures to maintain genome stability. Our investigation delves into how BLM and FANCJ respond to telomeric RS induced by the telomeric G4 ligand, RHPS4. To examine their individual and combined functions, we employed CRISPR/Cas9 to deplete BLM and siRNA to silence FANCJ in U251MG glioblastoma cells. Our results revealed a functional interplay between the two helicases: RHPS4 treatment led to increased FANCJ protein levels and telomeric recruitment in both wild-type and BLM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.